Cytokinetics Inc (NASDAQ:CYTK)
During the Trading Day
| 1.18 |  +0.05 / +4.42% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 1.18 |  0.00 / 0.00% |
Volume: 39.7K |
Latest CYTK News | Press Releases
No recent news for Cytokinetics Inc.
Today’s Trading
| Previous close | 1.13 |
| Today’s open | 1.13 |
| Day’s range | 1.10 - 1.18 |
| Volume | 830,574 |
| Average volume (3 months) | 1,205,674 |
| Market cap | $167.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +47.22% |
| Earnings growth (this year) | -4.86% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +88.98% |
| P/E ratio | NM |
| Price/Sales | 9.49 |
| Price/Book | 2.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRGTTargacept Inc | -0.01 | -0.18% |
| NUTRNutraceutical Intern... | +0.09 | +0.47% |
| BLGXBiologix Hair Inc | 0.00 | 0.00% |
| NATRNature's Sunshine Pr... | +0.05 | +0.32% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $7.6M |
| Annual profit (last year) | -$40.4M |
| Net profit margin | -534.07% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Robert I. Blum, MBA |
Chief Financial Officer, Secretary & Executive VP Sharon A. Barbari |
Corporate headquarters South San Francisco, California |
Forecasts
